TaiGen Biopharmaceuticals Holdings (4157.TWO) Earnings Analysis
TaiGen Biopharmaceuticals Holdings (4157.TWO) next reports earnings on 2026-08-26, consensus EPS -0.13 TWD. Last quarter (2026-05-11) it beat with EPS -0.0201 TWD vs -0.08 TWD est (+74.9%). It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E 106.13.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4157.TWO next report earnings?
| Next earnings date | 2026-08-26 |
|---|---|
| Consensus EPS estimate | -0.13 TWD |
| Revenue estimate | 0.00B |
4157.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | -0.0201 TWD | -0.08 TWD | +74.9% | Beat |
| 2025-03-13 | -0.03436 TWD | n/a | n/a | n/a |
| 2024-08-29 | 0.09 TWD | n/a | n/a | n/a |
Beat rate: 1/1 (100%) over reported quarters with consensus data.
4157.TWO valuation and analyst view
| Trailing P/E | 106.13 |
|---|---|
| Trailing EPS | 0.07517 TWD |
| Price / book | 5.76 |
| Dividend yield | 0.00% |
| Market cap | 6.14B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is TaiGen Biopharmaceuticals Holdings (4157.TWO)'s next earnings date?
TaiGen Biopharmaceuticals Holdings is next scheduled to report on 2026-08-26, with a consensus EPS estimate of -0.13 TWD and revenue estimate of 0.00B.
Did 4157.TWO beat earnings last quarter?
In its 2026-05-11 report, 4157.TWO posted EPS of -0.0201 TWD versus a -0.08 TWD estimate — a beat of 74.9%.
What is 4157.TWO's earnings track record?
Over the last 1 reported quarters with consensus data, 4157.TWO beat estimates 1 times (100%).
What is 4157.TWO's current P/E ratio and EPS?
4157.TWO trades at a trailing P/E of 106.13 on trailing EPS of 0.07516780597723627 TWD.
What do analysts rate 4157.TWO?
4157.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.